Skip to main content
. 2024 Nov 20;15:1496043. doi: 10.3389/fphar.2024.1496043

TABLE 2.

Drug combinations administered to the schizophrenic patients (n = 96).

Drug Category N Drug Category N
Acarbose capsules 0 91 Lorazepam tablets 0 80
1 5 1 16
Agomelatine tables 0 94 Metformin hydrochloride tablets 0 80
1 2 1 16
Alprazolam tablets 0 87 Nifedipine sustained-release tablets 0 93
1 9 1 3
Amlodipine besylate tablets 0 94 Oxazepam tablets 0 90
1 2 1 6
Aripiprazole tablets 0 80 Perphenazine tablets 0 92
1 16 1 4
Aspirin enteric-coated tablets 0 92 Propranolol hydrochloride tablets 0 79
1 4 1 17
Atorvastatin calcium tablets 0 91 Risperidone tablets 0 78
1 5 1 18
Clonazepam tablets 0 89 Silymarin capsules 0 94
1 7 1 2
Clozapine tablets 0 77 Sodium valproate sustained-release tablets 0 74
1 19 1 22
Duloxetine hydrochloride enteric-coated capsules 0 94 Spironolactone tablets 0 93
1 2 1 3
Fluvoxamine maleate tablets 0 94 Trihexyphenidyl hydrochloride tablets 0 73
1 2 1 23
Glimepiride tablets 0 91 Valsartan capsules 0 93
1 5 1 3
Lithium carbonate sustained-release tablets 0 80 Zopiclone tablets 0 87
1 16 1 9

Category, 0: without drug, 1: with drug; N, number of patients.